Business

Getting real about valuations in biotech

Article Abstract:

Valuation is the process by which companies and investors assess the worth of their products and programs and is used by companies to guide decisions on project development, licensing negotiations with partners and how equity is divided among investors and management. Valuations of biotech companies and their products are particularly difficult because of the long product development times, high risk of failure and susceptibility of business of changing market conditions.

The new fundamentalism

Article Abstract:

The increasing prominence of 'green activists' who approach the environmental issues in media and political circles is significant cause of concern as it imperils the future of the biotech enterprise and the health of society as a whole. The issue on which the green activists have focused most intensely is the genetic modifications of corp.